Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate vs 5-FU for Facial Actinic Keratosis
NCT02242747Completed
- Sponsor
- Universidade de São Paulo
- Start
- May 2014
- Primary completion
- Jul 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ingenol mebutate in actinic keratosis (AK) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Area under the Local Skin Reactions-Time Curve at Day 43. Started May 2014; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02242747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242747.